AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 38 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $188,000 | +213.3% | 19,000 | +69.6% | 0.01% | +300.0% |
Q4 2017 | $60,000 | -71.0% | 11,200 | -73.3% | 0.00% | -72.7% |
Q3 2017 | $207,000 | +283.3% | 42,002 | +195.8% | 0.01% | +266.7% |
Q2 2017 | $54,000 | +3.8% | 14,200 | +18.3% | 0.00% | -25.0% |
Q4 2016 | $52,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $891,000 | 15.31% |
Aisling Capital Management LP | 1,691,151 | $13,445,000 | 2.68% |
GREAT POINT PARTNERS LLC | 900,000 | $7,155,000 | 1.67% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $22,639,000 | 1.40% |
Altium Capital Management LP | 609,689 | $4,847,000 | 1.27% |
Sio Capital Management, LLC | 446,000 | $3,546,000 | 1.13% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,953,000 | 1.12% |
Samsara BioCapital, LLC | 883,720 | $7,026,000 | 1.10% |
Lion Point Capital, LP | 300,000 | $2,385,000 | 0.45% |
Abingworth LLP | 240,500 | $1,912,000 | 0.43% |